Updated adaptive servo-ventilation recommendations for the 2012 AASM guideline

"The treatment of central sleep apnea syndromes in adults: Practice parameters with an evidence-based literature review and meta-analyses"

R. Nisha Aurora, Sabin R Bista, Kenneth R. Casey, Susmita Chowdhuri, David A. Kristo, Jorge M. Mallea, Kannan Ramar, James A. Rowley, Rochelle S. Zak, Jonathan L. Heald

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

An update of the 2012 systematic review and meta-analyses were performed and a modified-GRADE approach was used to update the recommendation for the use of adaptive servo-ventilation (ASV) for the treatment of central sleep apnea syndrome (CSAS) related to congestive heart failure (CHF). Metaanalyses demonstrated an improvement in LVEF and a normalization of AHI in all patients. Analyses also demonstrated an increased risk of cardiac mortality in patients with an LVEF of ≤ 45% and moderate or severe CSA predominant sleep-disordered breathing. These data support a Standard level recommendation against the use of ASV to treat CHF-associated CSAS in patients with an LVEF of ≤ 45% and moderate or severe CSAS, and an Option level recommendation for the use of ASV in the treatment CHF-associated CSAS in patients with an LVEF > 45% or mild CHF-related CSAS. The application of these recommendations is limited to the target patient populations; the ultimate judgment regarding propriety of any specific care must be made by the clinician.

Original languageEnglish (US)
Pages (from-to)757-761
Number of pages5
JournalJournal of Clinical Sleep Medicine
Volume12
Issue number5
DOIs
StatePublished - 2016

Fingerprint

Central Sleep Apnea
Ventilation
Meta-Analysis
Guidelines
Heart Failure
Therapeutics
Health Services Needs and Demand
Sleep Apnea Syndromes
Mortality

Keywords

  • Adaptive servo-ventilation
  • Central sleep apnea
  • Clinical practice guideline

ASJC Scopus subject areas

  • Clinical Neurology
  • Pulmonary and Respiratory Medicine
  • Neurology

Cite this

Updated adaptive servo-ventilation recommendations for the 2012 AASM guideline : "The treatment of central sleep apnea syndromes in adults: Practice parameters with an evidence-based literature review and meta-analyses". / Aurora, R. Nisha; Bista, Sabin R; Casey, Kenneth R.; Chowdhuri, Susmita; Kristo, David A.; Mallea, Jorge M.; Ramar, Kannan; Rowley, James A.; Zak, Rochelle S.; Heald, Jonathan L.

In: Journal of Clinical Sleep Medicine, Vol. 12, No. 5, 2016, p. 757-761.

Research output: Contribution to journalArticle

Aurora, R. Nisha ; Bista, Sabin R ; Casey, Kenneth R. ; Chowdhuri, Susmita ; Kristo, David A. ; Mallea, Jorge M. ; Ramar, Kannan ; Rowley, James A. ; Zak, Rochelle S. ; Heald, Jonathan L. / Updated adaptive servo-ventilation recommendations for the 2012 AASM guideline : "The treatment of central sleep apnea syndromes in adults: Practice parameters with an evidence-based literature review and meta-analyses". In: Journal of Clinical Sleep Medicine. 2016 ; Vol. 12, No. 5. pp. 757-761.
@article{fef66160567c4073ac1708f56505521b,
title = "Updated adaptive servo-ventilation recommendations for the 2012 AASM guideline: {"}The treatment of central sleep apnea syndromes in adults: Practice parameters with an evidence-based literature review and meta-analyses{"}",
abstract = "An update of the 2012 systematic review and meta-analyses were performed and a modified-GRADE approach was used to update the recommendation for the use of adaptive servo-ventilation (ASV) for the treatment of central sleep apnea syndrome (CSAS) related to congestive heart failure (CHF). Metaanalyses demonstrated an improvement in LVEF and a normalization of AHI in all patients. Analyses also demonstrated an increased risk of cardiac mortality in patients with an LVEF of ≤ 45{\%} and moderate or severe CSA predominant sleep-disordered breathing. These data support a Standard level recommendation against the use of ASV to treat CHF-associated CSAS in patients with an LVEF of ≤ 45{\%} and moderate or severe CSAS, and an Option level recommendation for the use of ASV in the treatment CHF-associated CSAS in patients with an LVEF > 45{\%} or mild CHF-related CSAS. The application of these recommendations is limited to the target patient populations; the ultimate judgment regarding propriety of any specific care must be made by the clinician.",
keywords = "Adaptive servo-ventilation, Central sleep apnea, Clinical practice guideline",
author = "Aurora, {R. Nisha} and Bista, {Sabin R} and Casey, {Kenneth R.} and Susmita Chowdhuri and Kristo, {David A.} and Mallea, {Jorge M.} and Kannan Ramar and Rowley, {James A.} and Zak, {Rochelle S.} and Heald, {Jonathan L.}",
year = "2016",
doi = "10.5664/jcsm.5812",
language = "English (US)",
volume = "12",
pages = "757--761",
journal = "Journal of Clinical Sleep Medicine",
issn = "1550-9389",
publisher = "American Academy of Sleep Medicine",
number = "5",

}

TY - JOUR

T1 - Updated adaptive servo-ventilation recommendations for the 2012 AASM guideline

T2 - "The treatment of central sleep apnea syndromes in adults: Practice parameters with an evidence-based literature review and meta-analyses"

AU - Aurora, R. Nisha

AU - Bista, Sabin R

AU - Casey, Kenneth R.

AU - Chowdhuri, Susmita

AU - Kristo, David A.

AU - Mallea, Jorge M.

AU - Ramar, Kannan

AU - Rowley, James A.

AU - Zak, Rochelle S.

AU - Heald, Jonathan L.

PY - 2016

Y1 - 2016

N2 - An update of the 2012 systematic review and meta-analyses were performed and a modified-GRADE approach was used to update the recommendation for the use of adaptive servo-ventilation (ASV) for the treatment of central sleep apnea syndrome (CSAS) related to congestive heart failure (CHF). Metaanalyses demonstrated an improvement in LVEF and a normalization of AHI in all patients. Analyses also demonstrated an increased risk of cardiac mortality in patients with an LVEF of ≤ 45% and moderate or severe CSA predominant sleep-disordered breathing. These data support a Standard level recommendation against the use of ASV to treat CHF-associated CSAS in patients with an LVEF of ≤ 45% and moderate or severe CSAS, and an Option level recommendation for the use of ASV in the treatment CHF-associated CSAS in patients with an LVEF > 45% or mild CHF-related CSAS. The application of these recommendations is limited to the target patient populations; the ultimate judgment regarding propriety of any specific care must be made by the clinician.

AB - An update of the 2012 systematic review and meta-analyses were performed and a modified-GRADE approach was used to update the recommendation for the use of adaptive servo-ventilation (ASV) for the treatment of central sleep apnea syndrome (CSAS) related to congestive heart failure (CHF). Metaanalyses demonstrated an improvement in LVEF and a normalization of AHI in all patients. Analyses also demonstrated an increased risk of cardiac mortality in patients with an LVEF of ≤ 45% and moderate or severe CSA predominant sleep-disordered breathing. These data support a Standard level recommendation against the use of ASV to treat CHF-associated CSAS in patients with an LVEF of ≤ 45% and moderate or severe CSAS, and an Option level recommendation for the use of ASV in the treatment CHF-associated CSAS in patients with an LVEF > 45% or mild CHF-related CSAS. The application of these recommendations is limited to the target patient populations; the ultimate judgment regarding propriety of any specific care must be made by the clinician.

KW - Adaptive servo-ventilation

KW - Central sleep apnea

KW - Clinical practice guideline

UR - http://www.scopus.com/inward/record.url?scp=84969247002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969247002&partnerID=8YFLogxK

U2 - 10.5664/jcsm.5812

DO - 10.5664/jcsm.5812

M3 - Article

VL - 12

SP - 757

EP - 761

JO - Journal of Clinical Sleep Medicine

JF - Journal of Clinical Sleep Medicine

SN - 1550-9389

IS - 5

ER -